Email ID
Password
Forgotten your password?
Advanced Search
Home
Companies
Patients
Investigators
Trials & Research
Regulatory
Therapeutics
Trials&Research
LATEST NEWS
PharmaNet recruits children for hayfever drug trial
09 March 2010
PharmaNet Development Group Inc is looking for children to take part in a new Phase I/II trial of the Spanish pharmaceutical company Faes Farma ’s hayfever drug, Bilastine, a novel antihistamine. The company is looking for 44 patients between the ages of two and twelve with either allergic ...
What comes before Phase I?...
Robarts begins recruiting for Phase III trial of Asacol...
Quintiles extends its London research capabilities
08 March 2010
Quintiles has boosted its ability to handle Phase I trials and translational medicine initiatives with the opening of an extension to its central London facility. Located on the 14th floor of London's Guy's Hospital, the expansion adds 35 additional beds to the company's existing Phase I ...
Omnicomm launches Phase I trial management software
05 March 2010
OmniComm Systems has released TrialOne, a fully integrated web-based solution designed to automate the Phase I clinical trial process. TrialOne provides all necessary web-based tools used to recruit study volunteers, schedule screening appointments, collect screening data, directly capture ...
Kendle receives approval to build new Indian operations centre
04 March 2010
Kendle has received approval from Indian authorities to build of a new operations centre in a Special Economic Zone (SEZ) in the upcoming Ahmedabad-Gandhinagar Knowledge Corridor. The new SEZ centre represents an important and strategic investment for Kendle and demonstrates the company's ...
>> More Latest News...
FEATURES
Pfizer, Peakdale and in-house outsourcing
19 February 2010
The recent news that the contract research services firm Peakdale Molecular Ltd is to take up home within Pfizer's main European research hub as part of a new on-site working agreement, presents an innovative new slant on pharma outsourcing and puts a new spin on the relationship between pharma ...
Where to next.
01 February 2010
If one were to rank everything spoken by everyone working for a CRO or drug company over the past ten years by frequency of use, the phrase ‘emerging market’ would be right near the top. But what does it actually mean? The term continues to be applied to a number of relatively established markets – ...
Playing data capture catch-up in Japan
22 January 2010
Over the last decade Japan, despite being the second largest drug market in the world and possessing a notable R&D ability, has lagged behind the US and Europe in bringing drugs to market. Japan’s Pharmaceutical and Medical Device Agency (PMDA) calculated in its 2007 annual report that it took 2.5 ...
Clinical Trials in the Republic of Kazakhstan
19 January 2010
Although the potential of Kazakhstan has only recently begun to be exploited, and the number of clinical studies currently underway is comparatively small, its significance as a player in this market is predicted to grow rapidly. Kazakhstan boasts a centralised healthcare system with a large ...
>> More Features...
PEOPLE
ACM appoints Asia Pacific manager
ACM Global Central Laboratory has appointed a new general manager of Asia Pacific, Nandan Rao , who will spearhead the company's growth in India and Southeast Asia. His first responsibility will be to oversee trials conducted by ACM's partner laboratory, before building the company’s own local ...
Venn Life Sciences hires new VP of business development
Venn Life Sciences has hired Dale Trask as vice-president of global business development. Mr Trask brings extensive experience in CRO business development and will be responsible for enhancing Venn's business partnerships, strategic relationships and growth into new markets. Mr Trask joins Venn ...
Entest Biomedical adds CRO experience to scientific board
Entest BioMedical has appointed Dr Vladimir Bogin to its scientific advisory board (SAB). Dr Bogin is the CEO of CRO Cromos Pharma. The company feels the addition of Dr Bogin to the SAB will "greatly assist in developing its clinical protocols as it moves forward to conducting both preclinical and ...
>> More People...
COMMENTARY
Renal Failure: challenges and opportunities
The term renal failure describes a decline in the excretory function of the kidney due to a reduction in glomerular filtration rate. In adults, renal failure may be either acute, lasting from a few days to a few weeks, or chronic, lasting months to years. Acute renal failure is a medical ...
Filling the gaps
Most stakeholders in Europe are in favour of some form of EU centralised approval system for multinational clinical trials, with the pharmaceutical industry and the European Medicines Agency among the strongest backers for such a move. But the support is not unanimous: many national regulatory ...
The fight against malaria - all still to play for
If you didn't know, how many cases of malaria would you guess occur every year around the globe? A million? Two million? In fact, around 250 million cases of malaria occur each year. Most of these occur in developing countries, although malaria is also an issue for travellers from developed ...
UK wants harmonisation, not centralisation, of European trial approvals
The UK drug regulator, the MHRA, says it does not want a centralised approvals system for clinical trials in Europe, preferring instead the voluntary harmonisation project for authorising multinational studies that is currently being piloted in the EU. The MHRA also feels that introducing a single ...
EU promises multinational CTA harmonisation at last
The problem stems mainly from the way that the EU clinical trials Directive (2001/20/EC) has been implemented by the various member states. National authorities have different format, language and content requirements for clinical trial approvals, as well as different timelines for reviewing ...
Search continues for improved BPH treatments
The recent announcement by Boehringer Ingelheim that it plans to make the alpha blocker tamsulosin available without a prescription in the UK is a reflection of the continued interest in the benign prostatic hyperplasia (BPH) market. The condition affects some 15 million men across the seven major ...
>> More Commentary...
About Us
Getting Started
Subscribe
FREE Trial
Advertise
Awards
White Papers
EVENTS
Designing the Future Conditions for Clinical Research in Europe
17 March 2010
Brussels, Belgium
ICR Annual Spring Conference and Exhibition
19 April 2010
London, UK
CDISC Interchange Europe
26 April 2010
London, UK
